ImageneBio (IMA) Receivables - Other (2024 - 2025)

ImageneBio (IMA) posted Receivables - Other of $728000.0 for Q3 2025, up 777.11% sequentially from $83000.0 in Q4 2024.

ImageneBio (IMA) Receivables - Other (2024 - 2025) Analysis & Trends

ImageneBio has reported Receivables - Other for 2 years, with the latest figure at $728000.0 in Q3 2025.

Quarterly Receivables - Other changed N/A year-over-year to $728000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $728000.0 (changed N/A YoY) and the FY2024 annual result came in at $83000.0, changed N/A from the prior year.
Receivables - Other advanced to $728000.0 in Q3 2025 per IMA's latest filing, from $83000.0 in the prior quarter.
Over five years, Receivables - Other peaked at $728000.0 in Q3 2025 and troughed at $83000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.66 Bn	131.81 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.52 Bn	78.52 Bn	3.93 Bn
3	Argenx Se	65.30 Bn	60.11 Bn	1.37 Bn
4	Moderna	59.18 Bn	54.04 Bn	52.00 Mn
5	BeOne Medicines	42.08 Bn	36.98 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.77 Bn	28.46 Bn	992.69 Mn
7	BioNTech SE	28.13 Bn	9.74 Bn	668.28 Mn
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn
9	Royalty Pharma	27.16 Bn	26.32 Bn	-
10	ImageneBio	48.35 Mn	-87.00 Mn	-

Download Data